Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma.
Premužić V, Bašić-Kinda S, Radman I, Dujmović D, Ilić I, Živković N, Maleta L, Kralik M, Dobrenić M, Galunić-Bilić L, Rončević P, Vodanović M, Aurer I. Premužić V, et al. Among authors: vodanovic m. Medicine (Baltimore). 2023 May 19;102(20):e33675. doi: 10.1097/MD.0000000000033675. Medicine (Baltimore). 2023. PMID: 37335743 Free PMC article.
Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms.
Horvat I, Boban A, Zadro R, Antolic MR, Serventi-Seiwerth R, Roncevic P, Radman I, Sertic D, Vodanovic M, Pulanic D, Basic-Kinda S, Durakovic N, Zupancic-Salek S, Vrhovac R, Aurer I, Nemet D, Labar B. Horvat I, et al. Among authors: vodanovic m. Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):53-63. doi: 10.1016/j.clml.2018.08.020. Epub 2018 Sep 10. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30301673
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience.
Bašić-Kinda S, Radman I, Dujmović D, Ilić I, Kralik M, Dobrenić M, Galunić-Bilić L, Rončević P, Vodanović M, Sertić Z, Hude I, Aurer I. Bašić-Kinda S, et al. Among authors: vodanovic m. Ann Hematol. 2021 Jun;100(6):1517-1524. doi: 10.1007/s00277-020-04353-3. Epub 2020 Nov 20. Ann Hematol. 2021. PMID: 33216199
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases.
Bašić-Kinda S, Mišura Jakobac K, Sinčić-Petričević J, Deak D, Vodanović M, Jakić-Bubalo M, Mitrović Z, Grubešić A, Dreta B, Županić Krmek D, Coha B, Radić-Krišto D, Aurer I. Bašić-Kinda S, et al. Among authors: vodanovic m. Croat Med J. 2021 Oct 31;62(5):455-463. doi: 10.3325/cmj.2021.62.455-63. Croat Med J. 2021. PMID: 34730885 Free PMC article.
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem.
Sertić Z, Lucijanić M, Bašić-Kinda S, Serventi Seiwerth R, Periša V, Sertić D, Coha B, Pulanić D, Perić Z, Desnica L, Mikulić M, Vodanović M, Radman-Livaja I, Šegulja D, Rogić D, Valković T, Aurer I, Duraković N. Sertić Z, et al. Among authors: vodanovic m. Biomedicines. 2022 Nov 11;10(11):2892. doi: 10.3390/biomedicines10112892. Biomedicines. 2022. PMID: 36428459 Free PMC article.
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients-A Single Centre Experience.
Galunic Bilic L, Santek F, Mitrovic Z, Basic-Kinda S, Dujmovic D, Vodanovic M, Mandac Smoljanovic I, Ostojic Kolonic S, Galunic Cicak R, Aurer I. Galunic Bilic L, et al. Among authors: vodanovic m. Cancers (Basel). 2024 Feb 2;16(3):649. doi: 10.3390/cancers16030649. Cancers (Basel). 2024. PMID: 38339400 Free PMC article.
70 results